A mHealth Application as a Screening Tool for Neonatal Jaundice in Filipino Neonates

Sponsor
Picterus AS (Industry)
Overall Status
Completed
CT.gov ID
NCT05616845
Collaborator
Norwegian University of Science and Technology Faculty of Medicine and Health Sciences Department of Public Health and Nursing (Other), Gov. Celestino Gallares Memorial Hospital (Other)
69
1
1
24
87.5

Study Details

Study Description

Brief Summary

The purpose of the study is to test the reliability of the Picterus smartphone application in Filipino neonates. A descriptive cross-sectional study will be the method to understand the correlation of the modalities and to determine the reliability of the application

Condition or Disease Intervention/Treatment Phase
  • Device: Picterus Jaundice Pro
N/A

Detailed Description

The purpose of the study is to test the reliability of the Picterus smartphone application.

The study is designed for Filipino neonates, but implemented in other LMIC. The participants include newborns with or without jaundice, Gestational age >37 weeks, Age0-14days, Weight

2500 gram and absence of congenital malformations. Demographic data of the neonates will be collected together with all the performed tests and it will be stored in a secured system. Blood will be drawn and measure the bilirubin level of the neonates in a standard clinical routine and will be compared to the estimated bilirubin performed with the Picterus smartphone application.

A descriptive cross-sectional study will be the method to understand the correlation of the modalities and to determine the reliability of the application.

It will provide an answer to whether the Picterus smartphone application is reliable to other populations, especially to darker skin and with high melanin content such as Filipino neonates.

Study Design

Study Type:
Interventional
Actual Enrollment :
69 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
A mHealth Application as a Screening Tool for Neonatal Jaundice in Filipino Neonates
Actual Study Start Date :
Feb 2, 2022
Actual Primary Completion Date :
Feb 26, 2022
Actual Study Completion Date :
Feb 26, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Enable high qualitative estimation of bilirubin levels in the blood of new-borns

There is only one arm in this study which is to enable high qualitative estimation of bilirubin levels in the blood of new-borns with darker skin and with high melanin content such as Filipino neonates.

Device: Picterus Jaundice Pro
Use Picterus Jaundice Pro, a smartphone app that is used to take photo of the newborns skin, where the Picterus calibration card is place.
Other Names:
  • Picterus JP
  • Outcome Measures

    Primary Outcome Measures

    1. validate the reliability of the Picterus mHealth application as a screening tool for neonatal jaundice in Filipino neonates [5-10 minutes]

      Validation of smartphone-based screening tool (Picterus JP) for neonatal jaundice in newborns with high melanin content.

    Secondary Outcome Measures

    1. correlation between the estimated levels of bilirubin detected by the Picterus mHealth application and bilirubin serum levels in Filipino neonates [1-2 hours]

      correlation between the estimated levels of bilirubin detected by the Picterus mHealth application and bilirubin serum levels in Filipino neonates

    2. correlation between the estimated level of bilirubin detected by the Picterus mHealth application and transcutaneous bilirubinometer results in Filipino neonates. [5-10 minutes]

      correlation between the estimated level of bilirubin detected by the Picterus mHealth application and transcutaneous bilirubinometer results in Filipino neonates.

    3. correlation between the estimated level of bilirubin detected by the Picterus mHealth application and those obtained using visual Kramer scale in Filipino neonates. [5 minutes]

      correlation between the estimated level of bilirubin detected by the Picterus mHealth application and those obtained using visual Kramer scale in Filipino neonates.

    4. sensitivity, specificity, positive and negative predictive value between estimated bilirubin level of the digital images, Kramer examination and TcB. [5 months]

      sensitivity, specificity, positive and negative predictive value between estimated bilirubin level of the digital images, Kramer examination and TcB.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Day to 14 Days
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Newborns with or without jaundice

    • Gestational age ≥ 37 weeks

    • Age 0 - 14 days

    • Weight 2500 to 4500 grams

    • Absence of congenital malformations

    Exclusion Criteria:
    • Newborns with life-threatening conditions or significant illness

    • Newborns diagnosed with inborn errors of metabolism

    • Jaundiced newborns that have undergone phototherapy before screening

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Governor Celestino Gallares Memorial Hospital Tagbilaran City Bohol Philippines 6300

    Sponsors and Collaborators

    • Picterus AS
    • Norwegian University of Science and Technology Faculty of Medicine and Health Sciences Department of Public Health and Nursing
    • Gov. Celestino Gallares Memorial Hospital

    Investigators

    • Study Director: Jon Øyvind Odland, Prof,MD,PhD, NTNU Faculty of Medicine and Health Sciences, Department of Public Health and Nursing

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Picterus AS
    ClinicalTrials.gov Identifier:
    NCT05616845
    Other Study ID Numbers:
    • 322016
    First Posted:
    Nov 15, 2022
    Last Update Posted:
    Nov 23, 2022
    Last Verified:
    Nov 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 23, 2022